The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Ji Sung | - |
dc.contributor.author | Choi, Hoon | - |
dc.contributor.author | Noh, Tae Il | - |
dc.contributor.author | Tae, Jong Hyun | - |
dc.contributor.author | Yoon, Sung Goo | - |
dc.contributor.author | Kang, Seok Ho | - |
dc.contributor.author | Bae, Jae Hyun | - |
dc.contributor.author | Park, Hong Seok | - |
dc.contributor.author | Park, Jae Young | - |
dc.date.accessioned | 2021-09-04T15:23:01Z | - |
dc.date.available | 2021-09-04T15:23:01Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-06 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93336 | - |
dc.description.abstract | Purpose: This study was designed to estimate the value of a second transurethral resection of bladder tumor (TURBT) procedure in patients with initially diagnosed T1 high-grade bladder cancer. Materials and Methods: Between August 2009 and January 2013, a total of 29 patients with T1 high-grade bladder cancer prospectively underwent a second TURBT procedure. Evaluation included the presence of previously undetected residual tumor, changes to histopathological staging or grading, and tumor location. Recurrence-free and progression-free survival curves were generated to compare the prognosis between the groups with and without residual lesions by use of the Kaplan-Meier method. Results: Of 29 patients, 22 patients (75.9%) had residual disease after the second TURBT. Staging was as follows: no tumor, 7 (24.1%); Ta, 5 (17.2%); T1, 6 (20.7%); Tis, 6 (20.7%); Ta+Tis, 1 (3.4%); T1+Tis, 1 (3.4%); and >= T2, 3 (10.3%). The muscle layer was included in the surgical specimen after the initial TURBT in 24 patients (82.7%). In three patients whose cancer was upstaged to pT2 after the second TURBT, the initial surgical specimen contained the muscle layer. In the group with residual lesions, the 3-year recurrence-free survival and 3-year progression-free survival rates were 50% and 66.9%, respectively, whereas these rates were 68.6% and 68.6%, respectively, in the group without residual lesions. This difference was not statistically significant. Conclusions: Initial TURBT does not seem to be enough to control T1 high-grade bladder cancer. Therefore, a routine second TURBT procedure should be recommended in patients with T1 high-grade bladder cancer to accomplish adequate tumor resection and to identify patients who may need to undergo prompt cystectomy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN UROLOGICAL ASSOC | - |
dc.subject | INVASIVE UROTHELIAL CARCINOMA | - |
dc.subject | TRANSITIONAL-CELL CARCINOMA | - |
dc.subject | EAU GUIDELINES | - |
dc.subject | RECURRENCE | - |
dc.subject | CYSTECTOMY | - |
dc.subject | UPDATE | - |
dc.subject | IMPACT | - |
dc.subject | TRIAL | - |
dc.title | The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Seok Ho | - |
dc.contributor.affiliatedAuthor | Bae, Jae Hyun | - |
dc.contributor.affiliatedAuthor | Park, Hong Seok | - |
dc.contributor.affiliatedAuthor | Park, Jae Young | - |
dc.identifier.doi | 10.4111/kju.2015.56.6.429 | - |
dc.identifier.scopusid | 2-s2.0-84930856505 | - |
dc.identifier.wosid | 000358440900004 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF UROLOGY, v.56, no.6, pp.429 - 434 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF UROLOGY | - |
dc.citation.title | KOREAN JOURNAL OF UROLOGY | - |
dc.citation.volume | 56 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 429 | - |
dc.citation.endPage | 434 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001997631 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | INVASIVE UROTHELIAL CARCINOMA | - |
dc.subject.keywordPlus | TRANSITIONAL-CELL CARCINOMA | - |
dc.subject.keywordPlus | EAU GUIDELINES | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | CYSTECTOMY | - |
dc.subject.keywordPlus | UPDATE | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordAuthor | Neoplasm invasiveness | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Urinary bladder neoplasms | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.